Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice

Infection and Immunity

Volumn 70, Issue 9, 2002, Pages 5065-5074

  Schnapp, Anita R ^a   Eickhoff, Chris S ^a   Sizemore, Donata ^a   Curtiss III, Roy ^a   Hoft, Daniel F ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRUZIPAIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4 ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT CRUZIPAIN; TRYPANOSOMA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOCOMPATIBILITY; INFECTION RESISTANCE; MACROPHAGE; MEMORY CELL; MICROBIAL ATTENUATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; TH1 CELL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ADOPTIVE TRANSFER; ANIMALS; BASE SEQUENCE; CHAGAS DISEASE; CYSTEINE ENDOPEPTIDASES; DNA, PROTOZOAN; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; SALMONELLA TYPHIMURIUM; TH1 CELLS; TRYPANOSOMA CRUZI; VACCINES, SYNTHETIC;

EID: 0036718057     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.9.5065-5074.2002     Document Type: Article

References (62)

1. Functional diversity of helper T lymphocytes
2. Removal of endotoxin from protein solutions by phase separation using Triton X-114
3. +) T lymphocytes
4. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase
5. The C-terminal extension of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi
6. Stage and strain specific expression of the tandemly repeated 90 kDa surface antigen gene family in Trypanosoma cruzi
7. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease
8. A direct role for IFN-gamma in regulation of Th1 cell development
9. Detection of parasite DNA in Chagas' heart disease
10. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes
11. A major cysteine proteinase is developmentally regulated in Trypanosoma cruzi
12. Further characterization and partial amino acid sequence of a cysteine proteinase from Trypanosoma cruzi
13. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice
14. The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi
15. +-T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene
16. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring
17. 15N]nitrate in biological fluids
18. Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses
19. Trypanosoma cruzi expresses diverse repetitive protein antigens
20. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi
21. + Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi
22. Parasite antigen-induced IFN-gamma and IL-4 production by cells from pathopermissive and pathoresistant strains of mice infected with Trypanosoma cruzi
23. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy
24. Autoimmunity in Chagas disease cardiomyopathy: Fulfilling the criteria at last?
25. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine
26. Mechanisms of resistance against experimental Trypanosoma cruzi infection: The importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice
27. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies
28. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice
29. Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue
30. Identification of new cysteine protease gene isoforms in Trypanosoma cruzi
31. Antibody-dependent cell cytotoxicity against Trypanosoma cruzi is only mediated by protective antibodies
32. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections
33. The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains
34. Anomolous electrophoretic behaviour of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi in relation to its apparent molecular mass
35. + T lymphocytes
36. Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro
37. The surface protein superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that becomes anergic
38. Synergism between tumor necrosis factor-α and interferon-γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism
39. Glycoprotein GP57/51 of Trypanosoma cruzi: Structural and conformational epitopes defined with monoclonal antibodies
40. Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase
41. Construction of an asd+ expression-cloning vector: Stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain
42. High resolution localization of cruzipain and Ssp4 in Trypanosoma cruzi by replica staining label fracture
43. Isolation and functional characterization of murine T cell lines and clones specific for the protozoan parasite Trypanosoma cruzi
44. + T-cell clones: T helper type 1-like phenotype and reactivity with shed trypomastigote antigens
45. Trypanosoma cruzi surface antigens of blood and culture forms
46. + in chronic human Chagasic myocarditis: Correlation with the presence of myocardial Trypanosoma cruzi antigens
47. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8
48. Trypanosoma cruzi: Characterization and isolation of a 57/51,000 m.w. surface glycoprotein (GP57/51) expressed by epimastigotes and bloodstream trypomastigotes
49. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
50. + cells
51. DNA-based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection
52. Cell surface glycoproteins of Trypanosoma cruzi: Protective immunity in mice and antibody levels in human chagasic sera
53. Cysteine proteinase in Trypanosoma cruzi: Immunocytochemical localization and involvement in parasite-host cell interaction
54. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells
55. + T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi
56. Trypanosoma cruzi infection in MHC-deficient mice: Further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease
57. 2-microglobulin-deficient mice to Trypanosoma cruzi infection
58. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease
59. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue
60. + TC1 responses